WCG Wealth Advisors’s Boston Scientific BSX Stock Holding History

WCG Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,402	Closed	-$1.37M	–	524
2025 Q4	$1.37M	Buy	+14,402	New	+$1.41M	0.04%	312

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WCG Wealth Advisors's BSX Position: Q1 2026 in Review

WCG Wealth Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 14,402 shares — an estimated $1.37M sold.

WCG Wealth Advisors first reported a position in BSX in Q4 2025 and held it in 1 quarter. The position peaked at $1.37M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

WCG Wealth Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
WCG Wealth Advisors sold 14,402 Boston Scientific shares in Q1 2026, an estimated $1.37M.
WCG Wealth Advisors first reported a position in Boston Scientific in Q4 2025 and held it in 1 quarter.
WCG Wealth Advisors's Boston Scientific position peaked at $1.37M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on WCG Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.